Jim Simons
LTRN icon

Jim Simons’s Lantern Pharma LTRN Stock Holding History

Jim Simons’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
291,039
+175,039
+151% +$513K ﹤0.01% 2219
2026
Q1 		$159K Buy
116,000
+5,600
+5% +$15.7K ﹤0.01% 2955
2025
Q4 		$335K Buy
110,400
+10,300
+10% +$38.3K ﹤0.01% 2722
2025
Q3 		$435K Buy
100,100
+9,500
+10% +$39.7K ﹤0.01% 2855
2025
Q2 		$286K Buy
90,600
+1,800
+2% +$6.08K ﹤0.01% 3059
2025
Q1 		$314K Buy
88,800
+1,500
+2% +$6.22K ﹤0.01% 2917
2024
Q4 		$278K Buy
87,300
+3,300
+4% +$11.3K ﹤0.01% 3070
2024
Q3 		$308K Buy
84,000
+2,200
+3% +$9.06K ﹤0.01% 2974
2024
Q2 		$382K Buy
81,800
+16,100
+25% +$96.8K ﹤0.01% 2812
2024
Q1 		$578K Buy
65,700
+21,900
+50% +$117K ﹤0.01% 2802
2023
Q4 		$187K Buy
43,800
+5,700
+15% +$20.1K ﹤0.01% 3151
2023
Q3 		$130K Sell
38,100
-6,800
-15% -$30.9K ﹤0.01% 3194
2023
Q2 		$253K Buy
44,900
+20,300
+83% +$105K ﹤0.01% 3201
2023
Q1 		$119K Buy
24,600
+3,500
+17% +$18.4K ﹤0.01% 3434
2022
Q4 		$127K Sell
21,100
-200
-0.9% -$1K ﹤0.01% 3557
2022
Q3 		$102K Sell
21,300
-800
-4% -$4.3K ﹤0.01% 3593
2022
Q2 		$126K Buy
22,100
+11,400
+107% +$68K ﹤0.01% 3787
2022
Q1 		$77K Buy
+10,700
New +$71.5K ﹤0.01% 3836

Other funds holding LTRN

Empery Asset Management
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Quadrature Capital
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
NewEdge Advisors
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Jim Simons's LTRN Position: Q2 2026 in Review

Jim Simons increased its Lantern Pharma (LTRN) stake by 151% in Q2 2026, buying an estimated $513K and bringing the position to 291,039 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2219.

Jim Simons first reported a position in LTRN in Q1 2022 and has held it in 18 quarters since. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Jim Simons held 291,039 shares of Lantern Pharma worth $1.21M as of Q2 2026.
  • Jim Simons bought 175,039 Lantern Pharma shares in Q2 2026, an estimated $513K.
  • Lantern Pharma made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2219 holding.
  • Jim Simons first reported a position in Lantern Pharma in Q1 2022 and has held it in 18 quarters since.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.